DDInter1255 DDInter1180
Nadolol is a nonselective beta adrenal receptor blocker that is used to lower blood pressure.[L7922,L7925] Nonselective beta adrenal receptor blockers may no longer be first line in the treatment of hypertension as newer generations of beta adrenal receptor blockers have higher selectivity and offer better rates of adverse effects. Nadolol was granted FDA approval on 10 December 1979.
Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.
Nadolol {u} (Compound) resembles {v} (Compound) Carteolol
Nadolol {u} (Compound) treats {v} (Disease) hypertension
Nadolol {u} (Compound) binds {v} (Gene) ABCB1
Nadolol {u} (Compound) upregulates {v} (Gene) EVL
Nadolol {u} (Compound) downregulates {v} (Gene) CSRP1
Nadolol {u} (Compound) causes {v} (Side Effect) Body temperature increased
Nadolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Magaldrate
Nadolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Liothyronine
Nadolol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Scopolamine
Nadolol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Pasireotide
Nadolol (Compound) resembles Carteolol (Compound)
Nadolol (Compound) treats hypertension (Disease)
Nadolol (Compound) binds ABCB1 (Gene)
Nadolol (Compound) upregulates EVL (Gene)
Nadolol (Compound) downregulates CSRP1 (Gene)
Nadolol (Compound) causes Body temperature increased (Side Effect)
Nadolol may cause a minor interaction that can limit clinical effects when taken with Magaldrate
Nadolol may cause a minor interaction that can limit clinical effects when taken with Liothyronine
Nadolol may cause a moderate interaction that could exacerbate diseases when taken with Scopolamine
Nadolol may cause a moderate interaction that could exacerbate diseases when taken with Pasireotide